BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31602725)

  • 21. Atrial fibrillation associated with increased risk of venous thromboembolism. A population-based cohort study.
    Wang CC; Lin CL; Wang GJ; Chang CT; Sung FC; Kao CH
    Thromb Haemost; 2015 Jan; 113(1):185-92. PubMed ID: 25318828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amino-terminal B-natriuretic peptide levels and postablation recurrence in hypertensive patients with paroxysmal atrial fibrillation.
    Giannopoulos G; Kossyvakis C; Angelidis C; Efremidis M; Panagopoulou V; Letsas K; Bouras G; Vassilikos VP; Goudevenos J; Tousoulis D; Lekakis J; Deftereos S
    Heart Rhythm; 2015 Jul; 12(7):1470-5. PubMed ID: 25847478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status.
    Kristensen SL; Mogensen UM; Jhund PS; Rørth R; Anand IS; Carson PE; Desai AS; Pitt B; Pfeffer MA; Solomon SD; Zile MR; Køber L; McMurray JJV
    Circ Heart Fail; 2019 Mar; 12(3):e005766. PubMed ID: 30871349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac biomarkers predict mortality in emergency patients presenting with atrial fibrillation.
    Niederdöckl J; Simon A; Schnaubelt S; Schuetz N; Laggner R; Sulzgruber P; Spiel AO; Herkner H; Laggner AN; Domanovits H
    Heart; 2019 Mar; 105(6):482-488. PubMed ID: 30415208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of Future Atrial Fibrillation Development in Patients with Hypertrophic Cardiomyopathy: A Prospective Follow-Up Study.
    Tuluce K; Yakar Tuluce S; Kahya Eren N; Kocabas U; Akyildiz Akcay F; Gunduz R; Akyildiz ZI; Ergene O
    Echocardiography; 2016 Mar; 33(3):379-85. PubMed ID: 26493159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk stratification in acute pulmonary embolism: frequency and impact on treatment decisions and outcomes.
    Stamm JA; Long JL; Kirchner HL; Keshava K; Wood KE
    South Med J; 2014 Feb; 107(2):72-8. PubMed ID: 24926670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Raised plasma aldosterone and natriuretic peptides in atrial fibrillation.
    Dixen U; Ravn L; Soeby-Rasmussen C; Paulsen AW; Parner J; Frandsen E; Jensen GB
    Cardiology; 2007; 108(1):35-9. PubMed ID: 16968988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and Clinical Impact of Atrial Fibrillation in Patients with Pulmonary Embolism.
    Yang Y; Liu B; Taylor J; Huang Z; Gupta S; Thumma S; Wu L; Wang S; Everett G
    South Med J; 2020 Feb; 113(2):93-97. PubMed ID: 32016440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP.
    Rienstra M; Van Gelder IC; Van den Berg MP; Boomsma F; Van Veldhuisen DJ
    Europace; 2006 Jul; 8(7):482-7. PubMed ID: 16798760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlations between electrocardiogram and biomarkers in acute pulmonary embolism: Analysis of ZATPOL-2 Registry.
    Kukla P; Kosior DA; Tomaszewski A; Ptaszyńska-Kopczyńska K; Widejko K; Długopolski R; Skrzyński A; Błaszczak P; Fijorek K; Kurzyna M
    Ann Noninvasive Electrocardiol; 2017 Jul; 22(4):. PubMed ID: 28213932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation.
    Inohara T; Kim S; Pieper K; Blanco RG; Allen LA; Fonarow GC; Gersh BJ; Ezekowitz MD; Kowey PR; Reiffel JA; Naccarelli GV; Chan PS; Mahaffey KW; Singer DE; Freeman JV; Steinberg BA; Peterson ED; Piccini JP;
    Heart; 2019 Mar; 105(5):370-377. PubMed ID: 30228248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Value of Biomarkers in Acute Non-massive Pulmonary Embolism: A Systematic Review and Meta-analysis.
    Bajaj A; Rathor P; Sehgal V; Kabak B; Shetty A; Al Masalmeh O; Hosur S
    Lung; 2015 Oct; 193(5):639-51. PubMed ID: 26134045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation of atrial fibrillation burden and N-terminal pro-brain natriuretic peptide.
    Plitt DC; Chung EH; Mounsey JP; Schwartz JD; Pursell IW; Gehi AK
    Am J Cardiol; 2013 May; 111(9):1315-8. PubMed ID: 23415637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploration of pathophysiological pathways for incident atrial fibrillation using a multiplex proteomic chip.
    Molvin J; Jujic A; Melander O; Pareek M; Råstam L; Lindblad U; Daka B; Leosdottir M; Nilsson P; Olsen M; Magnusson M
    Open Heart; 2020; 7(1):e001190. PubMed ID: 32201587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation.
    Sharma A; Hijazi Z; Andersson U; Al-Khatib SM; Lopes RD; Alexander JH; Held C; Hylek EM; Leonardi S; Hanna M; Ezekowitz JA; Siegbahn A; Granger CB; Wallentin L
    Circulation; 2018 Oct; 138(16):1666-1676. PubMed ID: 29871978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-Term Influence of Radiofrequency Ablation on NT-proBNP, MR-proANP, Copeptin, and MR-proADM in Patients With Atrial Fibrillation: Data From the Observational SMURF Study.
    Charitakis E; Walfridsson H; Alehagen U
    J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27633393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk stratification of normotensive pulmonary embolism: prognostic impact of copeptin.
    Hellenkamp K; Schwung J; Rossmann H; Kaeberich A; Wachter R; Hasenfuß G; Konstantinides S; Lankeit M
    Eur Respir J; 2015 Dec; 46(6):1701-10. PubMed ID: 26493800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is atrial fibrillation associated with pulmonary embolism?
    Gex G; Gerstel E; Righini M; LE Gal G; Aujesky D; Roy PM; Sanchez O; Verschuren F; Rutschmann OT; Perneger T; Perrier A
    J Thromb Haemost; 2012 Mar; 10(3):347-51. PubMed ID: 22212132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy.
    Hijazi Z; Oldgren J; Andersson U; Connolly SJ; Ezekowitz MD; Hohnloser SH; Reilly PA; Vinereanu D; Siegbahn A; Yusuf S; Wallentin L
    Circulation; 2012 Apr; 125(13):1605-16. PubMed ID: 22374183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood Biomarkers of Heart Failure and Hypercoagulation to Identify Atrial Fibrillation-Related Stroke.
    Kneihsl M; Gattringer T; Bisping E; Scherr D; Raggam R; Mangge H; Enzinger C; Fandler-Höfler S; Eppinger S; Hermetter C; Bucnik B; Poltrum B; Niederkorn K; Fazekas F
    Stroke; 2019 Aug; 50(8):2223-2226. PubMed ID: 31216968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.